Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. - Wikidata - awgldk - TriplyDB

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

http://www.wikidata.org/entity/Q44860628

about

Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models Plasmacytoid dendritic cells: linking innate and adaptive immunity Pathogen recognition and inflammatory signaling in innate immune defenses Adjuvants: Classification, Modus Operandi, and Licensing Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities Induction and function of type I and III interferon in response to viral infection Toll-like receptors in antiviral innate immunity Decoding the complexity of type I interferon to treat persistent viral infections The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury.CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System Cell-cell fusion induced by measles virus amplifies the type I interferon response.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and Pathogenesis Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells Type I interferon is selectively required by dendritic cells for immune rejection of tumors T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26 Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)Regulation of the type I IFN induction: a current view Anti-retroviral effects of type I IFN subtypes in vivo Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells Immunosuppressive networks in the tumour environment and their therapeutic relevance p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus.Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity.Interferon induction and function at the mucosal surface.Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling Direct type I IFN but not MDA5/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation.Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes Safety, Tolerability, and Immunogenicity of Interferons The toll-Like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery.Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth.

P2860

Q21131160-4B0C7890-AB0F-4226-9790-767EAE4583D0 Q21245475-9248704B-0032-4740-9642-7C7103B43300 Q24558695-BFB407D8-5711-4652-A951-619DF15B7947 Q24643034-F89F6435-E37F-4885-9C13-0AE512B28D69 Q26747586-BC3E0BA3-1FF2-4168-8F73-F95D6C5A35A5 Q26782569-39B20E14-BD98-4CF8-8C7E-7F79565434CD Q26852437-43FE4EDA-DD3A-4422-9581-64E86DDF6660 Q27010065-2060B24E-8A54-4CC1-A6F6-CEBECCB5EE57 Q27011462-6F087170-2BD6-4569-B48E-70F4CA2848C7 Q27023801-6E87EB50-5FF4-4A48-989C-1C61B52EBCC2 Q27025082-D8953486-38EF-40E4-9ABE-A171F95A7EB1 Q27025559-0CEA28EB-5613-4298-AED8-887D4D7F5C40 Q27340815-BC5C6003-B354-4F44-A934-099CB4A5C76C Q27345078-8A5D5C21-55C6-4B64-8CCD-A64EA9143DF9 Q27470502-25DD5F46-882F-4766-8FD5-0A74A2006EBD Q27477717-AAB82543-C5B9-41C0-8F91-0F667D735446 Q27485028-A7CE3400-A09A-4A81-B2C5-249943BFAF9F Q28005535-DAC36095-E9C2-488C-B18C-BA2237265B0B Q28068881-858A8355-BE0E-48A6-8229-479F8755E50A Q28082128-A027B04D-411A-4BD6-91C4-782606A10324 Q28243702-1FE14894-FEA6-470D-B356-41AE8660AB03 Q28248489-C2936870-EF3C-4143-A860-2DA731FC3E2A Q28248500-80E4562C-F72D-41E4-BC19-253E51500C76 Q28264988-DFE16011-D446-457C-B07E-E339E2D245F9 Q28272127-B5267BA0-104F-4A02-8BA0-F3F248A3F508 Q28276339-FA78B329-0670-457E-8957-1590B59DD233 Q28585391-146C8B7A-6D3E-4CF2-800B-918051F41272 Q28730670-8EC3F6DB-C2A6-458E-AE70-B797C96B24D4 Q29619244-9EF77F5A-7256-4BE3-B00D-1FED3722E1C6 Q30409798-4F51C760-FC91-4326-869B-91994B963A9D Q30426385-71FE70B8-B9C6-4982-96E2-AE3126669B49 Q30661545-E98DA577-5DF9-4927-9E89-351FA4F43F00 Q31126452-AD23415E-2170-457B-B7FC-C6082284588C Q31147777-7BAA7196-621F-4253-A57A-20042E84C33A Q31152190-85CCFD2B-74FE-457C-9490-F909978FB05C Q33409032-D26BB61F-6D88-47A8-B6CD-D0C8BAFC09E6 Q33422966-53D22D62-10C5-4532-B391-6F0D9E0D07C0 Q33435810-C833B32B-D782-4791-9F33-B94EE0013A41 Q33490848-E8A25F2D-6DF2-4B21-BBA5-BC23C5147DBA Q33502208-986D9124-DF46-408E-A5A7-6A7B45BE1085

P2860

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

http://www.wikidata.org/entity/Q44860628

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@en

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@nl

type

label

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@en

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@nl

prefLabel

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@en

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@nl

P1433

Q44860628-A017B5C5-B0A4-4B8A-9D59-0461611756FB

P1476

Q44860628-65784A66-92F6-4A7F-9596-C7F054A19D8A

P2093

Q44860628-43BD062A-7DA0-48DA-B678-D57525C5BD83

Q44860628-4732FE99-176D-4A9B-87EB-4E7245159AA5

Q44860628-5203B50F-E202-4508-A290-5AF1EAA649D1

Q44860628-581F3E74-FB3D-465E-9283-F693E7D27AF8

Q44860628-5E5E4454-2848-4EBF-BD99-5A963B639AC3

Q44860628-613FD20F-6286-43FA-A540-C8752809B7E6

Q44860628-F5E45065-1CB0-4901-8E83-86DC84701E2F

Q44860628-F85D8BC3-C23D-4317-8434-5FD83BE74CAF

P304

Q44860628-1594FAF3-D19E-4F6E-8EE7-9B3AE7577AEB

P31

Q44860628-95C7BB33-B526-4446-9FF1-2F0243E3703F

P356

Q44860628-DBFC5104-D40D-44F7-A9EE-0A19C55FECF7

P407

Q44860628-4B8A7742-A7DB-42DE-88BA-6FE52660BC15

P433

Q44860628-BC8A2A86-57D4-42C8-B731-CE7881A875F2

P478

Q44860628-FBBCF242-99AC-455C-ADEA-9A972786B9B1

P577

Q44860628-DAA790C4-B8C0-41FE-A593-FFDBA8DC3CCB

P698

Q44860628-5808BA2E-FD72-4B0D-BCE8-C353DC0340DA

P356

P1433

Nature Immunology

P1476

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.

@en

P2093

Agnes Le Bon

http://www.w3.org/2001/XMLSchema#string

Cornelia Rossmann

http://www.w3.org/2001/XMLSchema#string

David F Tough

http://www.w3.org/2001/XMLSchema#string

Dirk Gewert

http://www.w3.org/2001/XMLSchema#string

Miranda Ashton

http://www.w3.org/2001/XMLSchema#string

Nathalie Etchart

http://www.w3.org/2001/XMLSchema#string

Persephone Borrow

http://www.w3.org/2001/XMLSchema#string

Sam Hou

http://www.w3.org/2001/XMLSchema#string

P304

1009-1015

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NI978

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14502286

http://www.w3.org/2001/XMLSchema#string